Guardant Health (NASDAQ:GH) Price Target Raised to $53.00 at Stifel Nicolaus
Guardant Health (NASDAQ:GH – Get Free Report) had its price target increased by equities research analysts at Stifel Nicolaus from $45.00 to $53.00 in a research note issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ target price indicates a potential upside of 23.63% from the company’s current […]
Guardant Health (NASDAQ:GH – Get Free Report) had its price target increased by equities research analysts at Stifel Nicolaus from $45.00 to $53.00 in a research note issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ target price indicates a potential upside of 23.63% from the company’s current […]
